Stay updated with breaking news from Michael Castagna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MannKind Co. (NASDAQ:MNKD – Free Report) – Analysts at Leerink Partnrs decreased their Q3 2024 EPS estimates for shares of MannKind in a research note issued to investors on Wednesday, February 28th. Leerink Partnrs analyst T. Smith now anticipates that the biopharmaceutical company will post earnings per share of $0.02 for the quarter, down from […]
MNKD earnings call for the period ending December 31, 2023.
MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript February 27, 2024 MannKind Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to MannKind Corporation 2023 Fourth Quarter and Full Year Financial Results Earnings Call. As a […]
MannKind Co. (NASDAQ:MNKD – Get Free Report) shares rose 10.6% during trading on Wednesday . The company traded as high as $4.26 and last traded at $4.18. Approximately 1,060,401 shares traded hands during trading, a decline of 56% from the average daily volume of 2,431,067 shares. The stock had previously closed at $3.78. Wall Street […]
MannKind Co. (NASDAQ:MNKD – Get Free Report)’s share price rose 10.6% during trading on Wednesday . The company traded as high as $4.26 and last traded at $4.18. Approximately 1,060,401 shares were traded during trading, a decline of 56% from the average daily volume of 2,431,067 shares. The stock had previously closed at $3.78. Analyst […]